Pegfilgrastim-induced hyperleukocytosis leading to hospitalization of a patient with breast cancer.

We describe a 45-year-old woman with breast cancer receiving dose-dense Adriamycin and cyclophosphamide chemotherapy. She presented with hyperleukocytosis after receiving pegfilgrastim, which resulted in hospitalization. This case report reviews the strategy to minimize the risk of hyperleukocytosis from pegfilgrastim administered in dose-dense chemotherapy. PMID: 31191148 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31191148?dopt=Abstract

Source: Baylor University Medical Center Proceedings - March 31, 2019 Category: Universities & Medical Training Authors: Chavda R, Herrington JD Tags: Proc (Bayl Univ Med Cent) Source Type: research